For example, a patient with a BMI of 28 and hypertension may be considered eligible even though they do not technically meet the obesity threshold
A growing number of lawsuits are being filed against Novo Nordisk alleging that its GLP-1 receptor agonist drugs, including Ozempic and Wegovy, caused users to suffer permanent vision loss due to non-arteritic anterior ischemic optic neuropathy (NAION)
At the Center for SmartLipo & Plastic Surgery, achieving your ideal contour often starts with medical optimization
I try to encourage every single one of my patients to seek out a body composition scale to at least get on it just once before they start a GLP-1, just so they already know their baseline lean body mass status, she says
4 Eli Lilly has said it expects to file for regulatory approval once the remaining TRIUMPH trials report results in 2026, and UK approval would follow shortly after
Patients beginning treatment today benefit from current options while positioning themselves to access future improvements
